The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
RNA binding protein PRRC2B mediates translation of specific mRNAs and regulates cell cycle progression
Open accessPreprint — published as 10.1093/nar/gkad322 · Paper page
Abstract
Accumulating evidence suggests that posttranscriptional control of gene expression, including RNA splicing, transport, modification, translation, and degradation, primarily relies on RNA binding proteins (RBPs). However, the functions of many RBPs remain understudied. Here, we characterized the function of a novel RBP, Proline-Rich Coiled-coil 2B (PRRC2B). Through photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation and sequencing (PAR-CLIP-seq), we identified transcriptome-wide CU- or GA-rich PRRC2B binding sites near the translation initiation codon on a specific cohort of mRNAs in HEK293T cells. These mRNAs, including oncogenes and cell cycle regulators such as CCND2 (cyclin D2), exhibited decreased translation upon PRRC2B knockdown as revealed by polysome-associated RNA-seq, resulting in reduced G1/S phase transition and cell proliferation. Antisense oligonucleotides blocking PRRC2B interactions with CCND2 mRNA decreased its translation, thus inhibiting G1/S transition and cell proliferation. Mechanistically, PRRC2B interactome analysis revealed RNA-independent interactions with eukaryotic translation initiation factors 3 (eIF3) and 4G2 (eIF4G2). The interaction with translation initiation factors is essential for PRRC2B function since the eIF3/eIF4G2-interacting defective mutant, unlike wild-type PRRC2B, failed to rescue the translation deficiency or cell proliferation inhibition caused by PRRC2B knockdown. Altogether, our findings reveal that PRRC2B is essential for efficiently translating specific proteins required for cell cycle progression and cell proliferation. Graphic Abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Flagged first, then by citations
Research works printed but not linked: 65
- 2018, A brave new world of RNA-binding proteins, Nat Rev Mol Cell Biol, 19, 327, 10.1038/nrm.2017.130 · DOI · Paper page
- 10.1038/nrm2178 · DOI
- Allain*., A.C.a.F.H.-T . (2011) From structure to function of RNA binding domains In RNA Binding Proteins, Zdravko L , ed. Landes Bioscience Springer Science+Business Media.
- 10.1038/s41586-020-2077-3 · DOI · Paper page
- 10.1016/j.febslet.2008.03.004 · DOI · Paper page
- 10.1016/j.molcel.2014.04.033 · DOI
- 10.1038/nrg3813 · DOI · Paper page
- 2021, RNA-binding proteins in human genetic disease, Nature Reviews Genetics, 22, 185, 10.1038/s41576-020-00302-y · DOI
- 2018, Trans-acting translational regulatory RNA binding proteins, WIREs RNA, 9, e1465, 10.1002/wrna.1465 · DOI
- Cockman, E. , Anderson, P. and Ivanov, P . (2020) TOP mRNPs: Molecular Mechanisms and Principles of Regulation. Biomolecules, 10. · DOI
- 10.1038/nrm.2017.103 · DOI · Paper page
- 10.1016/j.csbj.2019.10.001 · DOI
- 10.1038/nrm1488 · DOI · Paper page
- 10.1016/j.cell.2012.04.031 · DOI · Paper page
- 10.1016/j.ymeth.2017.07.006 · DOI
- 10.1016/j.molcel.2012.05.021 · DOI
- 10.1007/978-1-4939-3067-8_8 · DOI
- 10.1016/j.molcel.2013.05.021 · DOI
- 10.1093/nar/gkj109 · DOI · Paper page
- 2018, A widespread alternate form of cap-dependent mRNA translation initiation, Nature Communications, 9, 3068, 10.1038/s41467-018-05539-0 · DOI
- 10.1073/pnas.1617234114 · DOI
- 2021, Identification of key carcinogenic genes in Wilms’ tumor, Genes Genet Syst, 96, 141, 10.1266/ggs.21-00015 · DOI
- 10.1093/nar/gkx247 · DOI · Paper page
- 10.1016/j.leukres.2013.11.001 · DOI
- 10.21873/cgp.20053 · DOI
- 2019, Subependymal giant cell astrocytoma harboring a PRRC2B-ALK fusion: A case report, Pediatr Blood Cancer, 66, e27995, 10.1002/pbc.27995 · DOI
- 2021, Targeted Therapy in a Young Adult With a Novel Epithelioid Tumor Driven by a PRRC2B-ALK Fusion, J Natl Compr Canc Netw, 19, 1116
- 2022, Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report, Front Oncol, 12, 761558, 10.3389/fonc.2022.761558 · DOI
- 10.1007/978-1-4939-3067-8_10 · DOI
- 10.1093/bioinformatics/btw653 · DOI
- Martin, M . (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal; Vol 17, No 1: Next Generation Sequencing Data Analysis. · DOI · Paper page
- 10.1186/gb-2009-10-3-r25 · DOI · Paper page
- 10.1093/nar/gkv416 · DOI
- 10.1093/bioinformatics/btu170 · DOI · Paper page
- 10.1038/s41587-019-0201-4 · DOI · Paper page
- 10.1093/bioinformatics/btt656 · DOI · Paper page
- 10.1093/nar/gkaa1087 · DOI · Paper page
- 10.1186/s13059-014-0550-8 · DOI · Paper page
- 2021, clusterProfiler 4.0: A universal enrichment tool for interpreting omics data, Innovation (Camb, 2, 100141
- 10.1038/nmeth.2557 · DOI · Paper page
- 10.1083/jcb.66.1.188 · DOI
- 10.1093/nar/gkw907 · DOI
- 10.1161/CIRCRESAHA.119.315999 · DOI
- 10.1038/onc.2012.399 · DOI
- 10.1073/pnas.90.20.9571 · DOI
- 2012, Analyzing protein-protein interactions from affinity purification-mass spectrometry data with SAINT, Curr Protoc Bioinformatics, 8, 15
- 2021, RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site, Cell Rep, 37, 109934, 10.1016/j.celrep.2021.109934 · DOI
- 10.1038/s41467-022-35019-5 · DOI
- 10.1038/nature18954 · DOI
- 2015, CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer, Tumour Biol, 36, 1015, 10.1007/s13277-014-2706-2 · DOI
- 10.1038/onc.2009.437 · DOI
- 10.3892/ol.2016.5394 · DOI
- 10.1101/gad.1256504 · DOI · Paper page
- 2020, The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation, Genome Biol, 21, 195, 10.1186/s13059-020-02115-y · DOI
- 10.1038/emboj.2012.96 · DOI
- 10.1083/jcb.201206084 · DOI
- 10.1038/ncomms10153 · DOI
- 10.1038/nature11083 · DOI · Paper page
- Stonyte, V. , Boye, E. and Grallert, B . (2018) Regulation of global translation during the cell cycle. Journal of Cell Science, 131. · DOI
- 10.1038/s41422-018-0113-8 · DOI · Paper page
- 10.1016/j.molcel.2017.12.020 · DOI
- 10.1016/j.cell.2020.03.046 · DOI · Paper page
- Bohlen, J. , Roiuk, M. , Neff, M. and Teleman, A.A . (2023) PRRC2 proteins impact translation initiation by promoting leaky scanning. Nucleic Acids Res. · DOI
- 10.1038/ng.3970 · DOI · Paper page
- 10.1242/dmm.011957 · DOI
Metadata
- Authors
- Jiang, F., Hedaya, O. M., Khor, E., Wu, J., Auguste, M., & Yao, P.
- Affiliations
- University of Rochester Medicine (US)
- University of Rochester (US)
- Corresponding author
- Yao, Peng
- Venue
- Nucleic Acids Research
- Publisher
- openRxiv
- Published
- 2022-12-17
- Volume
- 51
- Issue
- 11
- Pages
- 5831-5846
- ISSN
- 0305-1048 (ISSN-L)
- PMC
- PMC10287950
- OpenAlex
- W4367598503
- Cited by
- 29
- References
- 1
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 11 · 2023: 5
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Heart Association (R01 HL147954, R01 HL132899, 848985)
- University of Rochester
- National Institutes of Health (848985)
- Medical Center, University of Rochester
- National Heart, Lung, and Blood Institute (R01HL147954, R01HL132899, R01HL164584, R01HL169432)
- National Institute of General Medical Sciences (T32GM068411)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- RNA-binding proteins, mRNA translation, post-transcriptional regulation, cyclin D2, G1/S transition, cell cycle progression, cell proliferation, eIF3, eIF4G2, translation initiation, oncogenes
- MeSH terms
- Cell Cycle, Cell Division, Humans, Protein Binding, RNA, Messenger, RNA-Binding Proteins, Eukaryotic Initiation Factor-3, Cyclin D2, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review